BL3000 Compared to Pantogar® in the Treatment of Telogen Effluvium in Women.

Summary

Study phase III, randomized, double-dummy, placebo controlled, single-center, of regarding the non-inferiority of the medication BL3000, when compared to Pantogar® treatment of telogen effluvium in women. Research product: BL3000. Reference product: Pantogar® List of Study Center: MAIN INVESTIGATOR STUDY CENTER FONE Medcin Skin Institute Sérgio Schalka 11 36835357

Timeline

Start

2023-01-01

Primary completion

2023-07-30

Completion

2023-07-30

Drugs

Indications